Ono Pharmaceutical Co., Ltd. (TYO:4528)
Japan · Delayed Price · Currency is JPY 1,928.50
-12.50 (-0.64%)
Nov 7, 2025, 3:30 PM JST
Ono Pharmaceutical Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | 52,701 | 59,328 | 163,734 | 143,532 | 105,025 | 100,890 | Upgrade |
Depreciation & Amortization | 34,171 | 26,894 | 18,140 | 17,451 | 17,721 | 15,820 | Upgrade |
Loss (Gain) From Sale of Assets | - | 7,981 | 14,885 | 1,498 | 3,404 | 2,307 | Upgrade |
Other Operating Activities | -9,279 | -45,211 | -57,338 | -6,655 | -34,284 | -34,057 | Upgrade |
Change in Accounts Receivable | -1,185 | 7,391 | -19,782 | -14,513 | -15,283 | -7,179 | Upgrade |
Change in Inventory | 13,225 | 12,435 | -3,420 | -2,945 | -2,464 | -6,107 | Upgrade |
Change in Accounts Payable | 5,774 | 18,786 | -5,734 | 18,654 | 8,177 | 6,361 | Upgrade |
Change in Other Net Operating Assets | 2,422 | -5,145 | 175 | 2,588 | -20,467 | -4,058 | Upgrade |
Operating Cash Flow | 102,300 | 82,459 | 110,660 | 159,610 | 61,829 | 73,977 | Upgrade |
Operating Cash Flow Growth | -5.85% | -25.48% | -30.67% | 158.15% | -16.42% | -0.24% | Upgrade |
Capital Expenditures | -6,535 | -5,431 | -4,020 | -5,340 | -5,497 | -7,018 | Upgrade |
Sale of Property, Plant & Equipment | 10 | 9 | 903 | 6 | 14 | 2 | Upgrade |
Cash Acquisitions | - | -364,816 | - | - | - | - | Upgrade |
Sale (Purchase) of Intangibles | -46,704 | -2,559 | -16,809 | -9,157 | -6,780 | -13,275 | Upgrade |
Investment in Securities | 36,712 | 236,764 | 69,290 | -84,731 | 19,969 | -36,866 | Upgrade |
Other Investing Activities | -1,155 | -752 | -1,287 | -1,037 | -1,668 | -429 | Upgrade |
Investing Cash Flow | -17,672 | -136,785 | 48,077 | -100,259 | 6,038 | -57,586 | Upgrade |
Long-Term Debt Issued | - | 150,000 | - | - | - | - | Upgrade |
Total Debt Issued | - | 150,000 | - | - | - | - | Upgrade |
Long-Term Debt Repaid | - | -15,000 | - | - | - | - | Upgrade |
Total Debt Repaid | -33,316 | -15,000 | - | - | - | - | Upgrade |
Net Debt Issued (Repaid) | -33,316 | 135,000 | - | - | - | - | Upgrade |
Repurchase of Common Stock | -1 | -1 | -50,010 | -1 | -30,007 | -3 | Upgrade |
Dividends Paid | -37,527 | -37,516 | -37,183 | -29,742 | -27,666 | -22,449 | Upgrade |
Other Financing Activities | -5 | -3,184 | -2,655 | -2,741 | -2,564 | -2,302 | Upgrade |
Financing Cash Flow | -70,849 | 94,299 | -89,848 | -32,484 | -60,237 | -24,754 | Upgrade |
Foreign Exchange Rate Adjustments | 1,190 | -1,548 | 1,116 | 155 | 436 | 403 | Upgrade |
Miscellaneous Cash Flow Adjustments | 1 | 1 | - | 1 | 1 | - | Upgrade |
Net Cash Flow | 14,970 | 38,426 | 70,005 | 27,023 | 8,067 | -7,960 | Upgrade |
Free Cash Flow | 95,765 | 77,028 | 106,640 | 154,270 | 56,332 | 66,959 | Upgrade |
Free Cash Flow Growth | -8.22% | -27.77% | -30.87% | 173.86% | -15.87% | 0.41% | Upgrade |
Free Cash Flow Margin | 19.01% | 15.82% | 21.21% | 34.50% | 15.59% | 21.65% | Upgrade |
Free Cash Flow Per Share | 203.82 | 163.97 | 222.15 | 315.90 | 113.45 | 134.13 | Upgrade |
Cash Interest Paid | 2,221 | 1,408 | 92 | 74 | 70 | 73 | Upgrade |
Cash Income Tax Paid | 25,865 | 44,060 | 56,431 | 6,637 | 34,293 | 34,060 | Upgrade |
Levered Free Cash Flow | - | 71,819 | 79,783 | 116,639 | 18,091 | 31,716 | Upgrade |
Unlevered Free Cash Flow | - | 72,725 | 79,861 | 116,694 | 18,143 | 31,782 | Upgrade |
Change in Working Capital | 20,236 | 33,467 | -28,761 | 3,784 | -30,037 | -10,983 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.